355 related articles for article (PubMed ID: 9636031)
1. Product inhibition of the hepatitis C virus NS3 protease.
Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
[TBL] [Abstract][Full Text] [Related]
2. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
3. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
Ingallinella P; Altamura S; Bianchi E; Taliani M; Ingenito R; Cortese R; De Francesco R; Steinkühler C; Pessi A
Biochemistry; 1998 Jun; 37(25):8906-14. PubMed ID: 9636032
[TBL] [Abstract][Full Text] [Related]
4. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction.
Leinbach SS; Bhat RA; Xia SM; Hum WT; Stauffer B; Davis AR; Hung PP; Mizutani S
Virology; 1994 Oct; 204(1):163-9. PubMed ID: 8091650
[TBL] [Abstract][Full Text] [Related]
6. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
Failla CM; Pizzi E; De Francesco R; Tramontano A
Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
[TBL] [Abstract][Full Text] [Related]
7. An in vitro assay for hepatitis C virus NS3 serine proteinase.
Bouffard P; Bartenschlager R; Ahlborn-Laake L; Mous J; Roberts N; Jacobsen H
Virology; 1995 May; 209(1):52-9. PubMed ID: 7747484
[TBL] [Abstract][Full Text] [Related]
8. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
[TBL] [Abstract][Full Text] [Related]
10. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
Tautz N; Kaiser A; Thiel HJ
Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
12. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
[TBL] [Abstract][Full Text] [Related]
14. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
[TBL] [Abstract][Full Text] [Related]
15. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
Yang SH; Lee CG; Song MK; Sung YC
Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
Hamill P; Jean F
Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
[TBL] [Abstract][Full Text] [Related]
17. Processing pathways of the hepatitis C virus proteins.
Lohmann V; Koch JO; Bartenschlager R
J Hepatol; 1996; 24(2 Suppl):11-9. PubMed ID: 8836884
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput radiometric assay for hepatitis C virus NS3 protease.
Cerretani M; Di Renzo L; Serafini S; Vitelli A; Gennari N; Bianchi E; Pessi A; Urbani A; Colloca S; De Francesco R; Steinkühler C; Altamura S
Anal Biochem; 1999 Jan; 266(2):192-7. PubMed ID: 9888975
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication.
Benureau Y; Warter L; Malcolm BA; Martin A
Virology; 2010 Oct; 406(2):228-40. PubMed ID: 20701941
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.
Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R
J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
